IDSA on X: New in CID: A #dengue vaccine candidate was efficacious against symptomatic dengue in children and adolescents over 3 years post-vaccination across 8 endemic countries. 📄: #IDSAJournals #ClinInfectDis
Por um escritor misterioso
Descrição

Frontiers Current Development and Challenges of Tetravalent Live

Dengue and Zika virus infections are enhanced by live attenuated

Four-year safety follow-up of the tetravalent dengue vaccine

Dengue Vaccine - an overview

Vaccines, Free Full-Text
Do you know - IPSF APRO - Asia Pacific Regional Office

Host immunity and vaccine development against Dengue virus

Dynamics of Dengue Disease Severity Determined by the Interplay
Dengue pre-vaccination screening test evaluation for the use of

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and
de
por adulto (o preço varia de acordo com o tamanho do grupo)